IDEXX Laboratories, Inc. (IDXX)
515.21
-11.86
(-2.25%)
USD |
NASDAQ |
Oct 06, 16:00
515.21
0.00 (0.00%)
After-Hours: 19:00
IDEXX Laboratories Cash from Investing (Quarterly) : -25.50M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -25.50M |
| March 31, 2026 | -33.54M |
| December 31, 2025 | -28.13M |
| September 30, 2025 | -44.87M |
| June 30, 2025 | -33.63M |
| March 31, 2025 | -29.61M |
| December 31, 2024 | -39.84M |
| September 30, 2024 | -27.37M |
| June 30, 2024 | -32.91M |
| March 31, 2024 | -106.94M |
| December 31, 2023 | -30.44M |
| September 30, 2023 | -27.84M |
| June 30, 2023 | -27.47M |
| March 31, 2023 | -39.51M |
| December 31, 2022 | -49.23M |
| September 30, 2022 | -49.20M |
| June 30, 2022 | -55.09M |
| March 31, 2022 | -41.84M |
| December 31, 2021 | -45.03M |
| September 30, 2021 | -49.68M |
| June 30, 2021 | -174.66M |
| March 31, 2021 | -24.59M |
| December 31, 2020 | -15.69M |
| September 30, 2020 | -19.46M |
| June 30, 2020 | -24.56M |
| Date | Value |
|---|---|
| March 31, 2020 | -49.67M |
| December 31, 2019 | -95.91M |
| September 30, 2019 | -37.33M |
| June 30, 2019 | -34.08M |
| March 31, 2019 | -38.21M |
| December 31, 2018 | -39.84M |
| September 30, 2018 | -54.22M |
| June 30, 2018 | -27.65M |
| March 31, 2018 | 260.31M |
| December 31, 2017 | -24.49M |
| September 30, 2017 | -41.49M |
| June 30, 2017 | -43.70M |
| March 31, 2017 | -29.01M |
| December 31, 2016 | -14.28M |
| September 30, 2016 | -22.95M |
| June 30, 2016 | -29.76M |
| March 31, 2016 | -23.80M |
| December 31, 2015 | -26.01M |
| September 30, 2015 | -54.81M |
| June 30, 2015 | -66.97M |
| March 31, 2015 | -160.62M |
| December 31, 2014 | -35.62M |
| September 30, 2014 | -23.45M |
| June 30, 2014 | -8.712M |
| March 31, 2014 | -12.63M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Neogen Corp. | -4.00M |
| QuidelOrtho Corp. | -107.30M |
| Aspira Women's Health, Inc. | -0.15M |
| VolitionRX Ltd. | -0.0016M |
| Lucid Diagnostics, Inc. | -0.021M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 347.16M |
| Cash from Financing (Quarterly) | -325.19M |
| Free Cash Flow | 1.233B |
| Free Cash Flow Per Share (Quarterly) | 4.043 |
| Free Cash Flow to Equity (Quarterly) | 329.99M |
| Free Cash Flow to Firm (Quarterly) | 329.92M |
| Free Cash Flow Yield | 2.99% |